Eastern Europe (UNSDG) vs Marshall Islands: Prevalence of anaemia in women aged 15-49
Eastern Europe (UNSDG)
23.46
in 2023
Marshall Islands
23.5
in 2023
Eastern Europe (UNSDG) rank
113th
Marshall Islands rank
115th
Prevalence of anaemia in women aged 15-49 over time
- Eastern Europe (UNSDG)
- Marshall Islands
How they compare
Marshall Islands currently reports 23.5 against 23.46 in Eastern Europe (UNSDG), a difference of 0.04.
Across all 24 years both countries report, Marshall Islands has been ahead every year.
Eastern Europe (UNSDG) ranks 113th and Marshall Islands ranks 115th of 155 groups.
Marshall Islands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern Europe (UNSDG) | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.03 | 22.69 | 3.66 | Marshall Islands |
| 2010s | 19.66 | 22.08 | 2.42 | Marshall Islands |
| 2020s | 22.4 | 22.95 | 0.5479 | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anaemia in women aged 15-49, Eastern Europe (UNSDG) or Marshall Islands?
- Marshall Islands, at 23.5 against 23.46 in Eastern Europe (UNSDG) as of 2023.
- What is the difference in prevalence of anaemia in women aged 15-49 between Eastern Europe (UNSDG) and Marshall Islands?
- 0.04, with Marshall Islands ahead.
- How many years of comparable data are there for Eastern Europe (UNSDG) and Marshall Islands?
- 24 years are reported by both, from 2000 to 2023.
- How do Eastern Europe (UNSDG) and Marshall Islands rank globally for prevalence of anaemia in women aged 15-49?
- Eastern Europe (UNSDG) ranks 113th and Marshall Islands ranks 115th of 155 groups.
- Where does this data come from?
- UNICEF, published as Prevalence of anaemia in women aged 15-49 (Modeled Estimates). Statizoid refreshes it automatically from the source and publishes the full history for both places.